Market News & Trends
Smart Gel May Pave Way for Next-Gen Drug Delivery
University of Birmingham scientists have developed a new material that changes from a gel to a liquid-like state under ultraviolet light and can be rebuilt…
New Agreement Marks LifeCore’s Thirteenth Late-State Program to Generate Revenue
Lifecore Biomedical, Inc., a fully integrated injectables CDMO, has signed a new agreement to transfer a commercially marketed product to the company’s pipeline. Under the…
3 Deaths From Experimental Cell Therapy; Novartis and BMS Pause CGT Trials
Reuters has reported that Novartis paused eight clinical trials of an experiment cell therapy, called rap-cel, targeting autoimmune and neurological disorders, after three patients died.…
Company’s First AI AI-Generated Design Goes Into Human Studies
BigHat Biosciences, a clinical-stage, AI-driven protein therapeutics platform company, today announced that the first patient has been dosed in its Phase 1 clinical trial evaluating…
Potential New Target Identified for Cancer Cachexia Therapy
Researchers at Helmholtz Munich, the Heidelberg Faculty of Medicine at Heidelberg University, the German Center for Diabetes Research (DZD) and the Technical University of Munich…
First Patient Dosed in Veloxis Pharmaceuticals Phase 2 Trial of Pegrizeprument for the Prevention of Organ Rejection in Kidney Transplant Recipients
Veloxis Pharmaceuticals, Inc., a global specialty pharmaceutical company part of Asahi Kasei Corporation, today announced that the first participant has been dosed in its Phase…
Pfizer and BioNTech Receive FDA Approval for XFG-Adapted COVID-19 Vaccine
Pfizer Inc. and BioNTech say the FDA has approved the supplemental Biologics License Application (sBLA) for the companies’ 2026-2027 COVID-19 vaccine formula targeting the XFG…
FDA Approves First-of-a-Kind Drug for Rare Blood Disorder
The Food and Drug Administration today approved Takeda Pharmaceuticals’ Mimrylo (rusfertide), a new treatment for adults with polycythemia vera, a rare blood disorder that causes…
Lilly’s $2.87B Acquisition of Merida Biosciences Advances Treatments for Autoimmune and Allergic Diseases
Eli Lilly and Company and Merida Biosciences, Inc., a biotechnology company advancing a new class of precision therapeutics for serious autoimmune and allergic diseases, announced…
Evonik expands lipid-based drug delivery capabilities with new GMP manufacturing facility in Vancouver
Evonik is investing in a new GMP drug product manufacturing facility for lipid-based drug delivery in Vancouver, Canada. The facility will increase Evonik’s development and…
Centrix Pharma Solutions and University of Sussex partner to advance data-driven pharmaceutical development
Centrix Pharma Solutions, a UK-based Contract Development Manufacturing Organization (CDMO) with strong scientific and manufacturing expertise, has partnered with the University of Sussex on a…
McKesson Signs Agreement to Acquire Precision Medicine Group, LLC
McKesson Corporation announced today that it signed a definitive agreement to acquire Precision Medicine Group, LLC, a global provider of clinical research and biopharma commercialization…
Hovione Completes Expansion of Loures Tablet Manufacturing Center Adding Commercial-Scale Batch Tableting Capacity
LOURES, Portugal – Hovione, a globally-integrated specialist pharmaceutical CDMO, has completed expansion of the company’s tablet development and manufacturing center at its main global campus…
Aptar Active Material Science first use of Activ-Film technology with a commercialized capsule-based Dry Powder Inhalation (DPI) drug product.
Aptar Active Material Science, part of AptarGroup, Inc. and a global leader in active material science solutions, announced its first use of Activ-Film technology with…
FDA Approves IMAAVY (nipocalimab-aahu) for the treatment of warm autoimmune hemolytic anemia
The U.S. FDA approved IMAAVY (nipocalimab-aahu) for the treatment of warm autoimmune hemolytic anemia (wAIHA) - a rare, life-threatening autoantibody disease - in adults and pediatric…
Purdue small-molecule inhibitors shown to promote robust antitumor immunity
WEST LAFAYETTE, Ind. — Researchers in Purdue University’s College of Pharmacy have developed and validated a novel series of small-molecule inhibitors that promote antitumor immunity and hold…
Erasca Granted FDA Fast Track Designation for Pan-RAS Molecular Glue ERAS-0015
SAN DIEGO, -- Erasca, Inc. , a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers,…
Smithers Germany Medical Device Testing Lab Achieves ISO/IEC 17025 Accreditation
(Akron, Ohio, USA) — Smithers, a leading provider of testing, consulting, information, and compliance services, announces that its Germany Medical Device Testing laboratory is formally…
Evonik provides customers with Life Cycle Assessment data for selected EUDRAGIT polymers
Essen, Germany. Evonik now offers its customers cradle-to-gate LCA data for selected EUDRAGIT functional polymers. These results are derived from Evonik’s TÜV-certified LCA method. This…
Bespak Awarded Gold EcoVadis Sustainability Rating for its Holmes Chapel Site
Holmes Chapel, UK, Bespak, the specialist inhalation CDMO, has achieved a Gold EcoVadis sustainability rating for its Holmes Chapel site. The result places Bespak among…
